Organometallic half-sandwich iridium anticancer complexes

Journal of Medicinal Chemistry

Volumn 54, Issue 8, 2011, Pages 3011-3026

  Liu, Zhe ^a   Habtemariam, Abraha ^a   Pizarro, Ana M ^a   Fletcher, Sally A ^a   Kisova, Anna ^b   Vrana, Oldrich ^b   Salassa, Luca ^a   Bruijnincx, Pieter C A ^a,c   Clarkson, Guy J ^a   Brabec, Viktor ^b   Sadler, Peter J ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ETHIDIUM BROMIDE; ETHYLENEDIAMINE; GUANINE; IRIDIUM COMPLEX; ORGANOMETALLIC COMPOUND; PICOLINIC ACID; PLASMID DNA;

ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG BINDING; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROPHOBICITY; OVARY CANCER; VISCOSITY;

CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; IRIDIUM; MODELS, MOLECULAR; ORGANOMETALLIC COMPOUNDS;

EID: 79955419401     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm2000932     Document Type: Article

References (110)

1. Kelland, L. The Resurgence of Platinum-Based Cancer Chemotherapy Nat. Rev. Cancer 2007, 7, 573-584 (Pubitemid 47106628)
2. Wang, D.; Lippard, S. J. Cellular Processing of Platinum Anticancer Drugs Nat. Rev. Drug Discovery 2005, 4, 307-320 (Pubitemid 41130944)
3. Halpern, J. Organometallic Chemistry at the Threshold of a New Millennium. Retrospect and Prospect Pure Appl. Chem. 2001, 73, 209-220
4. Fish, R. H.; Jaouen, G. Bioorganometallic Chemistry: Structural Diversity of Organometallic Complexes with Bioligands and Molecular Recognition Studies of Several Supramolecular Hosts with Biomolecules, Alkali-Metal Ions, and Organometallic Pharmaceuticals Organometallics 2003, 22, 2166-2177
5. Medicinal Organometallic Chemistry (Topics in Organometallic Chemistry), 1 st ed.; Jaouen, G.; Metzler-Nolte, N., Eds.; Springer-Verlag: Heidelberg, Germany, 2010; Vol. 32.
6. Hartinger, C. G.; Dyson, P. J. Bioorganometallic Chemistry-From Teaching Paradigms to Medicinal Applications Chem. Soc. Rev. 2009, 38, 391-401
7. Yan, Y. K.; Melchart, M.; Habtemariam, A.; Sadler, P. J. Organometallic Chemistry, Biology and Medicine: Ruthenium Arene Anticancer Complexes Chem. Commun. 2005, 4764-4776 (Pubitemid 41509143)
8. Suss-Fink, G. Arene Ruthenium Complexes as Anticancer Agents Dalton Trans. 2010, 39, 1673-1688
9. Mendoza-Ferri, M. G.; Hartinger, C. G.; Mendoza, M. A.; Groessl, M.; Egger, A. E.; Eichinger, R. E.; Mangrum, J. B.; Farrell, N. P.; Maruszak, M.; Bednarski, P. J.; Klein, F.; Jakupec, M. A.; Nazarov, A. A.; Severin, K.; Keppler, B. K. Transferring the Concept of Multinuclearity to Ruthenium Complexes for Improvement of Anticancer Activity J. Med. Chem. 2009, 52, 916-925
10. - Inorg. Chem. 2008, 47, 8589-8591
11. Aird, R. E.; Cummings, J.; Ritchie, A. A.; Muir, M.; Morris, R. E.; Chen, H.; Sadler, P. J.; Jodrell, D. I. In Vitro and in Vivo Activity and Cross Resistance Profiles of Novel Ruthenium (II) Organometallic Arene Complexes in Human Ovarian Cancer Br. J. Cancer 2002, 86, 1652-1657 (Pubitemid 34628122)
12. Tobe, M. L.; Burgess, J. Inorganic Reaction Mechanisms; Addison Wesley Longman Inc.: Essex, 1999.
13. Lay, P. A.; Harman, W. D. In Advances in Inorganic Chemistry; Sykes, A. G., Ed.; Academic Press: New York, 1991; Vol. 37, pp 219 - 379.
14. Helm, L.; Merbach, A. E. Water Exchange on Metal Ions: Experiments and Simulations Coord. Chem. Rev. 1999, 187, 151-181
15. Richens, D. T. Ligand Substitution Reactions at Inorganic Centers Chem. Rev. 2005, 105, 1961-2002 (Pubitemid 40951779)
16. Cleare, M. J. Transition Metal Complexes in Cancer Chemotherapy Coord. Chem. Rev. 1974, 12, 349-405
17. Sava, G.; Giraldi, T.; Mestroni, G.; Zassinovich, G. Antitumor Effects of Rhodium(I), Iridium(I) and Ruthenium(II) Complexes in Comparison with cis-dichlorodiammino Platinum(II) in Mice Bearing Lewis Lung Carcinoma Chem.-Biol. Interact. 1983, 45, 1-6 (Pubitemid 13033471)
18. Sava, G.; Zorzet, S.; Perissin, L.; Mestroni, G.; Zassinovich, G.; Bontempi, A. Coordination Metal Complexes of Rh(I), Ir(I) and Ru(II): Recent Advances on Antimetastatic Activity on Solid Mouse Tumors Inorg. Chim. Acta 1987, 137, 69-71
19. Giraldi, T.; Sava, G.; Mestroni, G.; Zassinovich, G.; Stolfa, D. Antitumour Action of Rhodium(I) and Iridium(I) Complexes Chem.-Biol. Interact. 1978, 22, 231-238 (Pubitemid 9048272)
20. Köpf-Maier, P. Complexes of Metals Other Than Platinum as Antitumour Agents Eur. J. Clin. Pharmacol. 1994, 47, 1-16 (Pubitemid 24281305)
21. Casini, A.; Edafe, F.; Erlandsson, M.; Gonsalvi, L.; Ciancetta, A.; Re, N.; Ienco, A.; Messori, L.; Peruzzini, M.; Dyson, P. J. Rationalization of The Inhibition Activity of Structurally Related Organometallic Compounds Against the Drug Target Cathepsin B by DFT Dalton Trans. 2010, 39, 5556-5563
22. Amouri, H.; Moussa, J.; Renfrew, A. K.; Dyson, P. J.; Rager, M. N.; Chamoreau, L.-M. Discovery, Structure, and Anticancer Activity of an Iridium Complex of Diselenobenzoquinone Angew. Chem., Int. Ed. Engl. 2010, 49, 7530-7533
23. Ali Nazif, M.; Bangert, J.-A.; Ott, I.; Gust, R.; Stoll, R.; Sheldrick, W. S. Dinuclear Organoiridium(III) mono- and bis-intercalators with Rigid Bridging Ligands: Synthesis, Cytotoxicity and DNA Binding J. Inorg. Biochem. 2009, 103, 1405-1414
24. Wirth, S.; Rohbogner, C.; Cieslak, M.; Kazmierczak-Baranska, J.; Donevski, S.; Nawrot, B.; Lorenz, I.-P. Rhodium(III) and Iridium(III) Complexes with 1,2-naphthoquinone-1-oximate as a Bidentate Ligand: Synthesis, Structure, and Biological Activity J. Biol. Inorg. Chem. 2010, 15, 429-440
25. Gras, M.; Therrien, B.; Süss-Fink, G.; Casini, A.; Edafe, F.; Dyson, P. J. Anticancer Activity of New Organo-Ruthenium, Rhodium and Iridium Complexes Containing the 2-(pyridine-2-yl)thiazole N,N-chelating Ligand J. Organomet. Chem. 2010, 695, 1119-1125
26. 5-pentamethylcyclopentadienyl)-iridium(III)- dipyridoquinoxaline and -dipyridophenazine Complexes J. Organomet. Chem. 2007, 692, 1300-1309 (Pubitemid 46209182)
27. Kokoschka, M.; Bangert, J. A.; Stoll, R.; Sheldrick, W. S. Sequence-Selective Organoiridium DNA bis-intercalators with Flexible Dithiaalkane Linker Chains Eur. J. Inorg. Chem. 2010, 1507-1515
28. 5)Ir] Fragment and the Anticancer Activity of the Resulting Complexes Angew. Chem., Int. Ed. Engl. 2010, 49, 8304-8305
29. Leung, S.-K.; Kwok, K. Y.; Zhang, K. Y.; Lo, K. K.-W. Design of Luminescent Biotinylation Reagents Derived from Cyclometalated Iridium(III) and Rhodium(III) Bis(pyridylbenzaldehyde) Complexes Inorg. Chem. 2010, 49, 4984-4995
30. Shao, F.; Barton, J. K. Long-Range Electron and Hole Transport through DNA with Tethered Cyclometalated Iridium(III) Complexes J. Am. Chem. Soc. 2007, 129, 14733-14738 (Pubitemid 350207886)
31. 5-pentamethylcyclopentadienyl Rhodium(III) and Iridium(III) Complexes with Quinolin-8-ol and Their Cytostatic Activity Polyhedron 2010, 29, 1653-1659
32. Wilbuer, A.; Vlecken, D. H.; Schmitz, D. J.; Kräling, K.; Harms, K.; Bagowski, C. P.; Meggers, E. Iridium Complex with Antiangiogenic Properties Angew. Chem., Int. Ed. Engl. 2010, 49, 3839-3842
33. 2], (II), Complexes J. Inorg. Biochem. 2003, 95, 37-46 (Pubitemid 36434404)
34. Marcon, G.; Casini, A.; Mura, P.; Messori, L.; Bergamo, A.; Orioli, P. Biological Properties of IRIM, the Iridium(III) Analogue of (Imidazolium (Bisimidazole) Tetrachlororuthenate) (ICR) Metal-Based Drugs 2000, 7, 195-200
35. Peacock, A. F. A.; Habtemariam, A.; Moggach, S. A.; Prescimone, A.; Parsons, S.; Sadler, P. J. Chloro Half-Sandwich Osmium(II) Complexes: Influence of Chelated N,N-Ligands on Hydrolysis, Guanine Binding, and Cytotoxicity Inorg. Chem. 2007, 46, 4049-4059
36. Chen, H.; Parkinson, J. A.; Morris, R. E.; Sadler, P. J. Highly Selective Binding of Organometallic Ruthenium Ethylenediamine Complexes to Nucleic Acids: Novel Recognition Mechanisms J. Am. Chem. Soc. 2003, 125, 173-186 (Pubitemid 36068656)
37. Liu, H.-K.; Berners-Price, S. J.; Wang, F.; Parkinson, J. A.; Xu, J.; Bella, J.; Sadler, P. J. Diversity in Guanine-Selective DNA Binding Modes for an Organometallic Ruthenium Arene Complex Angew. Chem., Int. Ed. Engl. 2006, 45, 8153-8156 (Pubitemid 44974150)
38. II Anticancer Complex Chem. Sci. 2010, 258-270
39. Liu, S.; Rebros, M.; Stephens, G.; Marr, A. C. Adding Value to Renewables: A One Pot Process Combining Microbial Cells and Hydrogen Transfer Catalysis to Utilise Waste Glycerol from Biodiesel Production Chem. Commun. 2009, 2308-2310
40. Hanasaka, F.; Fujita, K.-i.; Yamaguchi, R. Synthesis of New Iridium N-Heterocyclic Carbene Complexes Bearing a Functionalized Cp* Ligand and Their High Catalytic Activities in the Oppenauer-Type Oxidation of Alcohol Organometallics 2006, 25, 4643-4647 (Pubitemid 44412280)
41. Ito, M.; Endo, Y.; Tejima, N.; Ikariya, T. Bifunctional Triflylamide-Tethered Cp′Rh and Cp′Ir Complexes: A New Entry for Asymmetric Hydrogenation Catalysts Organometallics 2010, 29, 2397-2399
42. Kohl, G.; Pritzkow, H.; Enders, M. Rhodium(III) and Iridium(III) Complexes with Quinolyl-Functionalized Cp Ligands: Synthesis and Catalytic Hydrogenation Activity Eur. J. Inorg. Chem. 2008, 4230-4235
43. Pontes da Costa, A.; Viciano, M.; Sanaú, M.; Merino, S.; Tejeda, J.; Peris, E.; Royo, B. First Cp*-Functionalized N-Heterocyclic Carbene and Its Coordination to Iridium. Study of the Catalytic Properties Organometallics 2008, 27, 1305-1309 (Pubitemid 351489736)
44. Liu, Z.; Habtemariam, A.; Pizarro, A. M.; Fletcher, S.; Clarkson, G.; Sadler, P. J. ISBOMC' 10, 5th International Symposium on Bioorganometallic Chemistry; Ruhr-University: Bochum, Germany, 2010; p 32.
45. III complex containing ethylenediamine was unsuccessful, and so, this complex is not reported.
46. Pizarro, A. M.; Habtemariam, A.; Sadler, P. J. In Medicinal Organometallic Chemistry (Topics in Organometallic Chemistry), 1 st ed.; Jaouen, G.; Metzler-Nolte, N., Ed.; Springer-Verlag: Heidelberg, Germany, 2010; Vol. 32, pp 21 - 56.
47. Hohmann, H.; Hellquist, B.; Van Eldik, R. Kinetics and Mechanism of the Complex Formation Reactions of Diaqua(ethylenediamine)- and Diaqua(tetraethylethylenediamine)palladium(II) with the Purine Nucleosides Adenosine and Inosine Inorg. Chem. 1992, 31, 345-351
48. Martin, R. B. In Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug; Lippert, B., Ed.; VHCA & Wiley-VCH: Zürich, Switzerland, 1999; pp 181 - 205.
49. Jennerwein, M.; Andrews, P. A. Effect of Intracellular Chloride on the Cellular Pharmacodynamics of cis-diamminedichloroplatinum(II) Drug Metab. Dispos. 1995, 23, 178-184
50. 2O J. Inorg. Biochem. 2004, 98, 161-166 (Pubitemid 37495021)
51. Zhang, C. X.; Lippard, S. J. New Metal Complexes as Potential Therapeutics Curr. Opin. Chem. Biol. 2003, 7, 481-489 (Pubitemid 36980839)
52. Deubel, D. V.; Lau, J. K.-C. In Silico Evolution of Substrate Selectivity: Comparison of Organometallic Ruthenium Complexes with the Anticancer Drug Cisplatin Chem. Commun. 2006, 2451-2453 (Pubitemid 43877074)
53. Mendoza-Ferri, M.-G.; Hartinger, C. G.; Eichinger, R. E.; Stolyarova, N.; Severin, K.; Jakupec, M. A.; Nazarov, A. A.; Keppler, B. K. Influence of the Spacer Length on the in Vitro Anticancer Activity of Dinuclear Ruthenium-Arene Compounds Organometallics 2008, 27, 2405-2407
54. Gramatica, P.; Papa, E.; Luini, M.; Monti, E.; Gariboldi, M.; Ravera, M.; Gabano, E.; Gaviglio, L.; Osella, D. Antiproliferative Pt(IV) Complexes: Synthesis, Biological Activity, and Quantitative Structure-Activity Relationship Modeling J. Biol. Inorg. Chem. 2010, 15, 1157-1169
55. Loh, S. Y.; Mistry, P.; Kelland, L. R.; Abel, G.; Harrap, K. R. Reduced Drug Accumulation as a Major Mechanism of Acquired Resistance to Cisplatin in a Human Ovarian Carcinoma Cell line: Circumvention Studies Using Novel Platinum (II) and (IV) Ammine/amine Complexes Br. J. Cancer 1992, 66, 1109-1115 (Pubitemid 23006152)
56. Oldfield, S. P.; Hall, M. D.; Platts, J. A. Calculation of Lipophilicity of a Large, Diverse Dataset of Anticancer Platinum Complexes and the Relation to Cellular Uptake J. Med. Chem. 2007, 50, 5227-5237 (Pubitemid 47585720)
57. Jaouen, G., Ed.; Bioorganometallics: Biomolecules, Labeling, Medicine; Wiley-VCH: Weinheim, Germany, 2006.
58. Chen, H.; Parkinson, J. A.; Parsons, S.; Coxall, R. A.; Gould, R. O.; Sadler, P. J. Organometallic Ruthenium(II) Diamine Anticancer Complexes: Arene-Nucleobase Stacking and Stereospecific Hydrogen-Bonding in Guanine Adducts J. Am. Chem. Soc. 2002, 124, 3064-3082 (Pubitemid 34249981)
59. Kostrhunova, H.; Florian, J.; Novakova, O.; Peacock, A. F. A.; Sadler, P. J.; Brabec, V. DNA Interactions of Monofunctional Organometallic Osmium(II) Antitumor Complexes in Cell-Free Media J. Med. Chem. 2008, 51, 3635-3643 (Pubitemid 351875019)
60. Novakova, O.; Chen, H.; Vrana, O.; Rodger, A.; Sadler, P. J.; Brabec, V. DNA Interactions of Monofunctional Organometallic Ruthenium(II) Antitumor Complexes in Cell-Free Media Biochemistry 2003, 42, 11544-11554 (Pubitemid 37205749)
61. Fernández, R.; Melchart, M.; Habtemariam, A.; Parsons, S.; Sadler, P. J. Use of Chelating Ligands to Tune the Reactive Site of Half-Sandwich Ruthenium(II)-Arene Anticancer Complexes Chem.-Eur. J. 2004, 10, 5173-5179
62. Habtemariam, A.; Melchart, M.; Fernández, R.; Parsons, S.; Oswald, I. D. H.; Parkin, A.; Fabbiani, F. P. A.; Davidson, J. E.; Dawson, A.; Aird, R. E.; Jodrell, D. I.; Sadler, P. J. Structure-Activity Relationships for Cytotoxic Ruthenium(II) Arene Complexes Containing N,N-, N,O-, and O,O-Chelating Ligands J. Med. Chem. 2006, 49, 6858-6868 (Pubitemid 44749753)
63. II complexes, for example, Sundquist, W. J.; Bancroft, D. P.; Lippard, S. J. Synthesis, Characterization, and Biological Activity of cis-diammineplatinum(II) Complexes of the DNA Intercalators 9-aminoacridine and Chloroquine J. Am. Chem. Soc. 1990, 112, 1590-1596 (Pubitemid 20129682)
64. Ma, Z.; Choudhury, J. R.; Wright, M. W.; Day, C. S.; Saluta, G.; Kucera, G. L.; Bierbach, U. A. A Non-Cross-Linking Platinum-Acridine Agent with Potent Activity in Non-Small-Cell Lung Cancer J. Med. Chem. 2008, 51, 7574-7580
65. Bugarcic, T.; Nováková, O.; Halámiková, A.; Zerzánková, L.; Vrána, O. i.; Kašpá rková, J.; Habtemariam, A.; Parsons, S.; Sadler, P. J.; Brabec, V. Cytotoxicity, Cellular Uptake, and DNA Interactions of New Monodentate Ruthenium(II) Complexes Containing Terphenyl Arenes J. Med. Chem. 2008, 51, 5310-5319
66. 2+ Inorg. Chem. 1999, 38, 4309-4316
67. Dobereiner, G. E.; Crabtree, R. H. Dehydrogenation as a Substrate-Activating Strategy in Homogeneous Transition-Metal Catalysis Chem. Rev. 2009, 110, 681-703
68. Oro, L. A.; Claver, C., Eds. Iridium Complexes in Organic Synthesis; Wiley-VCH Verlag GmbH & Co. KgaA: Weinheim, Germany, 2009.
69. 5- pentamethylcyclopentadienyl)-iridium(III)-dipyridoquinoxaline and -dipyridophenazine Complexes J. Organomet. Chem. 2007, 692, 1300-1309 In contrast, in the present report, dual mode DNA base binding and intercalation is possible for complexes 5 and 6.
70. 2Ir Bridging Systems Inorg. Chem. 1977, 16, 1488-1494
71. 4 J. Organomet. Chem. 1989, 363, 197-208
72. 2-P,S Ligands Eur. J. Inorg. Chem. 2005, 4840-4844 (Pubitemid 41771351)
73. 2N,N′)iridium(III) Trifluoromethanesulfonate Acta Crystallogr. 2007, E63, m1111-m1113
74. Koelle, U. Organometallic Aqua Ions of the Transition Metals Coord. Chem. Rev. 1994, 135-136, 623-650 (Pubitemid 124001850)
75. Bugarcic, T.; Habtemariam, A.; Stepankova, J.; Heringova, P.; Kasparkova, J.; Deeth, R. J.; Johnstone, R. D. L.; Prescimone, A.; Parkin, A.; Parsons, S.; Brabec, V.; Sadler, P. J. The Contrasting Chemistry and Cancer Cell Cytotoxicity of Bipyridine and Bipyridinediol Ruthenium(II) Arene Complexes Inorg. Chem. 2008, 47, 11470-11486
76. Wang, F.; Habtemariam, A.; van der Geer, E. P. L.; Fernández, R.; Melchart, M.; Deeth, R. J.; Aird, R.; Guichard, S.; Fabbiani, F. P. A.; Lozano-Casal, P.; Oswald, I. D. H.; Jodrell, D. I.; Parsons, S.; Sadler, P. J. Controlling Ligand Substitution Reactions of Organometallic Complexes: Tuning Cancer Cell Cytotoxicity Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 18269-18274 (Pubitemid 43011216)
77. Peacock, A. F. A.; Habtemariam, A.; Fernández, R.; Walland, V.; Fabbiani, F. P. A.; Parsons, S.; Aird, R. E.; Jodrell, D. I.; Sadler, P. J. Tuning the Reactivity of Osmium(II) and Ruthenium(II) Arene Complexes under Physiological Conditions J. Am. Chem. Soc. 2006, 128, 1739-1748 (Pubitemid 43214890)
78. Peacock, A. F. A.; Parsons, S.; Sadler, P. J. Tuning the Hydrolytic Aqueous Chemistry of Osmium Arene Complexes with N,O-Chelating Ligands to Achieve Cancer Cell Cytotoxicity J. Am. Chem. Soc. 2007, 129, 3348-3357 (Pubitemid 46449365)
79. Wang, F.; Chen, H.; Parsons, S.; Oswald, I. D. H.; Davidson, J. E.; Sadler, P. J. Kinetics of Aquation and Anation of Ruthenium(II) Arene Anticancer Complexes, Acidity and X-ray Structures of Aqua Adducts Chem.-Eur. J. 2003, 9, 5810-5820
80. Wang, F.; Bella, J.; Parkinson, J. A.; Sadler, P. J. Competitive Reactions of a Ruthenium Arene Anticancer Complex with Histidine, Cytochrome c and an Oligonucleotide J. Biol. Inorg. Chem. 2005, 10, 147-155 (Pubitemid 40569009)
81. Wang, F.; Xu, J.; Habtemariam, A.; Bella, J.; Sadler, P. J. Competition between Glutathione and Guanine for a Ruthenium(II) Arene Anticancer Complex: Detection of a Sulfenato Intermediate J. Am. Chem. Soc. 2005, 127, 17734-17743 (Pubitemid 43003385)
82. Reedijk, J. Bioinorganic Chemistry Special Feature: New Clues for Platinum Antitumor Chemistry: Kinetically Controlled Metal Binding to DNA Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 3611-3616 (Pubitemid 36422584)
83. Fukamachi, T.; Chiba, Y.; Wang, X.; Saito, H.; Tagawa, M.; Kobayashi, H. Tumor Specific Low pH Environments Enhance the Cytotoxicity of Lovastatin and Cantharidin Cancer Lett. 2010, 297, 182-189
84. + (dppz = dipyrido[3,2- a:2′,3′- c ]phenazine, n = 1-3), with S-coordinated Amino Acids (Aa) or Peptide J. Chem. Soc., Dalton Trans. 2002, 966-974 (Pubitemid 35202092)
85. 5-pentamethylcyclopentadienyl)rhodium(III) Species Inorg. Chim. Acta 2000, 307, 115-124
86. Yamanari, K.; Ito, R.; Yamamoto, S.; Konno, T.; Fuyuhiro, A.; Kobayashi, M.; Arakawa, R. Diastereomeric Separations and Crystal Structures of Rhodium(III) and Iridium(III) Complexes Containing Adenosine and Related Nucleosides Dalton Trans. 2003, 380-386
87. Yamanari, K.; Ito, R.; Yamamoto, S.; Konno, T.; Fuyuhiro, A.; Fujioka, K.; Arakawa, R. Cyclic Tetramers Composed of Rhodium(III), Iridium(III), or Ruthenium(II) Half-Sandwich and 6-Purinethiones Inorg. Chem. 2002, 41, 6824-6830
88. van Rijt, S. H.; Peacock, A. F. A.; Johnstone, R. D. L.; Parsons, S.; Sadler, P. J. Organometallic Osmium(II) Arene Anticancer Complexes Containing Picolinate Derivatives Inorg. Chem. 2009, 48, 1753-1762
89. van Rijt, S. H.; Mukherjee, A.; Pizarro, A. M.; Sadler, P. J. Cytotoxicity, Hydrophobicity, Uptake, and Distribution of Osmium(II) Anticancer Complexes in Ovarian Cancer Cells J. Med. Chem. 2010, 53, 840-849
90. Jung, Y.; Lippard, S. J. Direct Cellular Responses to Platinum-Induced DNA Damage Chem. Rev. 2007, 107, 1387-1407 (Pubitemid 46864967)
91. In separate experiments, we have shown that complex 6 is significantly more active towards wild-type CHO-K1 cells as compared to its mutant cell line MMC-2, which carries an ERCC3/XPB mutation (ERCC3 is an ATP-dependent DNA helicase that plays an essential role in nucleotide excision repair). Thus, cells that are deficient in DNA repair are more sensitive to killing by complex 6. This suggests that the cell must remove or bypass DNA lesions if it is to survive treatment and implies that unrepaired DNA damage contributes to its cytotoxicity. These data will be reported elsewhere.
92. Keck, M. V.; Lippard, S. J. Unwinding of Supercoiled DNA by Platinum-Ethidium and Related Complexes J. Am. Chem. Soc. 1992, 114, 3386-3390
93. Kasparkova, J.; Marini, V.; Najajreh, Y.; Gibson, D.; Brabec, V. DNA Binding Mode of the Cis and Trans Geometries of New Antitumor Nonclassical Platinum Complexes Containing Piperidine, Piperazine, or 4-Picoline Ligand in Cell-Free Media. Relations to Their Activity in Cancer Cell Lines Biochemistry 2003, 42, 6321-6332 (Pubitemid 36605136)
94. Satyanarayana, S.; Dabrowiak, J. C.; Chaires, J. B. Neither Δ- nor Î -tris(phenanthroline)ruthenium(II) Binds to DNA by Classical Intercalation Biochemistry 1992, 31, 9319-9324
95. Morris, R. E.; Aird, R. E.; del Socorro Murdoch, P.; Chen, H.; Cummings, J.; Hughes, N. D.; Parsons, S.; Parkin, A.; Boyd, G.; Jodrell, D. I.; Sadler, P. J. Inhibition of Cancer Cell Growth by Ruthenium(II) Arene Complexes J. Med. Chem. 2001, 44, 3616-3621 (Pubitemid 33026669)
96. Barry, N. P. E.; Edafe, F.; Dyson, P. J.; Therrien, B. Anticancer Activity of Osmium Metalla-Rectangles Dalton Trans 2010, 39, 2816-2820
97. Peacock, A. F. A.; Sadler, P. J. Medicinal Organometallic Chemistry: Designing Metal Arene Complexes as Anticancer Agents Chem. Asian J. 2008, 3, 1890-1899
98. Allen, O. R.; Gott, A. L.; Hartley, J. A.; Hartley, J. M.; Knox, R. J.; McGowan, P. C. Functionalised Cyclopentadienyl Titanium Compounds as Potential Anticancer Drugs Dalton Trans. 2007, 5082-5090 (Pubitemid 350015430)
99. Tan, Y. L. K.; Pigeon, P.; Hillard, E. A.; Top, S.; Plamont, M.-A.; Vessieres, A.; McGlinchey, M. J.; Muller-Bunz, H.; Jaouen, G. Synthesis, Oxidation Chemistry and Cytotoxicity Studies on Ferrocene Derivatives of Diethylstilbestrol Dalton Trans. 2009, 10871-10881
100. CrysAlis PRO; Oxford Diffraction Ltd.: Abington, Oxfordshire, United Kingdom, 2007.
101. Sheldrick, G. M. Phase Annealing in SHELX-90: Direct Methods for Larger Structures Acta Crystallogr. 1990, A46, 467-473
102. Sheldrick, G. M. SHELXL-97; University of Göttingen: Göttingen, Germany, 1997.
103. Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A., Jr.; Vreven, T.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, O.; Malick, D. K.; Rabuck, A. D.; Raghavachari, K.; Foresman, J. B.; Ortiz, J. V.; Cui, Q.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian 03, revision D.01; Gaussian, Inc.: Wallingford, CT, 2003.
104. Adamo, C.; Barone, V. Toward Reliable Density Functional Methods without Adjustable Parameters: The PBE0Model J. Chem. Phys. 1999, 110, 6158-6170
105. Hay, P. J.; Wadt, W. R. Ab Initio Effective Core Potentials For Molecular Calculations. Potentials for the Transition Metal Atoms Sc to Hg J. Chem. Phys. 1985, 82, 270-283
106. McLean, A. D.; Chandler, G. S. Contracted Gaussian Basis Sets for Molecular Calculations. I. Second Row Atoms, Z = 11-18 J. Chem. Phys. 1980, 72, 5639-5648
107. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening J. Natl. Cancer Inst. 1990, 82, 1107-1112 (Pubitemid 20213250)
108. Novakova, O.; Kasparkova, J.; Vrana, O.; van Vliet, P. M.; Reedijk, J.; Brabec, V. Correlation between Cytotoxicity and DNA Binding of Polypyridyl Ruthenium Complexes Biochemistry 1995, 34, 12369-12378
109. Butour, J.-L.; Macquet, J.-P. Differentiation of DNA • Platinum Complexes by Fluorescence Eur. J. Biochem. 1977, 78, 455-463
110. 2] Eur. J. Biochem. 1991, 202, 975-980